These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1506005)

  • 1. Different role of cytokine mediators in septic shock related to meningococcal disease and surgery/polytrauma.
    Waage A; Aasen AO
    Immunol Rev; 1992 Jun; 127():221-30. PubMed ID: 1506005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock.
    Derkx B; Marchant A; Goldman M; Bijlmer R; van Deventer S
    J Infect Dis; 1995 Jan; 171(1):229-32. PubMed ID: 7798670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of correlation between soluble CD14 and IL-6 in meningococcal septic shock.
    Arranz E; Blanco-Quirós A; Solís P; Garrote JA
    Pediatr Allergy Immunol; 1997 Nov; 8(4):194-9. PubMed ID: 9553985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis.
    Riché FC; Cholley BP; Panis YH; Laisné MJ; Briard CG; Graulet AM; Guéris JL; Valleur PD
    Crit Care Med; 2000 Feb; 28(2):433-7. PubMed ID: 10708179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inflammation mediators in pathogenesis of infection-toxic shock of meningococcal etiology].
    Val'kov AIu; Khodasevich LS
    Arkh Patol; 2000; 62(2):52-7. PubMed ID: 10789019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock.
    Sfeir T; Saha DC; Astiz M; Rackow EC
    Crit Care Med; 2001 Jan; 29(1):129-33. PubMed ID: 11176172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock.
    Kornelisse RF; Hazelzet JA; Savelkoul HF; Hop WC; Suur MH; Borsboom AN; Risseeuw-Appel IM; van der Voort E; de Groot R
    J Infect Dis; 1996 May; 173(5):1148-56. PubMed ID: 8627066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections.
    van Deuren M; van der Ven-Jongekrijg J; Bartelink AK; van Dalen R; Sauerwein RW; van der Meer JW
    J Infect Dis; 1995 Aug; 172(2):433-9. PubMed ID: 7622886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the interleukin-6/soluble interleukin-6 receptor axis in meningococcal septic shock.
    Pathan N; Williams EJ; Oragui EE; Stephens AC; Levin M
    Crit Care Med; 2005 Aug; 33(8):1839-44. PubMed ID: 16096463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current understanding of the pathogenesis of gram-negative shock.
    Waage A; Brandtzaeg P; Espevik T; Halstensen A
    Infect Dis Clin North Am; 1991 Dec; 5(4):781-91. PubMed ID: 1783767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannose-binding lectin is a critical factor in systemic complement activation during meningococcal septic shock.
    Sprong T; Mollnes TE; Neeleman C; Swinkels D; Netea MG; van der Meer JW; van Deuren M
    Clin Infect Dis; 2009 Nov; 49(9):1380-6. PubMed ID: 19793001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A myocardial cytotoxic process is involved in the cardiac dysfunction of meningococcal septic shock.
    Thiru Y; Pathan N; Bignall S; Habibi P; Levin M
    Crit Care Med; 2000 Aug; 28(8):2979-83. PubMed ID: 10966282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation.
    Brandtzaeg P; Høgåsen K; Kierulf P; Mollnes TE
    J Infect Dis; 1996 Mar; 173(3):647-55. PubMed ID: 8627028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of innate cytokine production capacity on clinical manifestation and severity of pediatric meningococcal disease.
    Sprong T; van der Ven-Jongekrijg J; Neeleman C; van der Meer JW; van Deuren M
    Crit Care Med; 2009 Oct; 37(10):2812-8. PubMed ID: 19707127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans.
    Dofferhoff AS; de Jong HJ; Bom VJ; van der Meer J; Limburg PC; de Vries-Hospers HG; Marrink J; Mulder PO; Weits J
    Scand J Infect Dis; 1992; 24(2):197-204. PubMed ID: 1641597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial dysfunction in meningococcal septic shock: no clear answer yet.
    van Deuren M; Brandtzaeg P
    Crit Care Med; 2005 Aug; 33(8):1884-6. PubMed ID: 16096482
    [No Abstract]   [Full Text] [Related]  

  • 17. Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes.
    Brandtzaeg P; Osnes L; Ovstebø R; Joø GB; Westvik AB; Kierulf P
    J Exp Med; 1996 Jul; 184(1):51-60. PubMed ID: 8691149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Western blot analysis of bile or intestinal fluid from patients with septic shock or systemic inflammatory response syndrome, using antibodies to TNF-alpha, IL-1 alpha and IL-1 beta.
    Belov L; Meher-Homji V; Putaswamy V; Miller R
    Immunol Cell Biol; 1999 Feb; 77(1):34-40. PubMed ID: 10101684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proinflammatory and anti-inflammatory cytokines in meningococcal disease.
    Riordan FA; Marzouk O; Thomson AP; Sills JA; Hart CA
    Arch Dis Child; 1996 Nov; 75(5):453-4. PubMed ID: 8957964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.
    Waage A; Brandtzaeg P; Halstensen A; Kierulf P; Espevik T
    J Exp Med; 1989 Jan; 169(1):333-8. PubMed ID: 2783334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.